E-Bulletin
November 16, 2023

Prior Authorization Added for LOQTORZI™

Holiday Closure

Our offices will be closed in observance of the Thanksgiving holiday on Thursday, Nov. 23 and Friday, Nov. 24. We will return to office, Monday, Nov. 27.

Prior Authorization Added for LOQTORZI™

Please note that BCBSWY requires authorization for LOQTORZI™ (toripalimab-tpzi). This is the first and only PD-1 inhibitor for the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma.

Medical Policy Reminder

As a reminder, be sure to check our Medical Policy for regular updates. Our Medical Policy can be found at BCBSWY.com/providers/policy/

Coding Advice, emergency protocol, medication authorizations

May 12, 2025

L8699 Update

April 29, 2025

Provider Updates Moving Platforms

April 4, 2025

Redirection of Care Update – addition of Saphnelo

March 27, 2025

SURGICAL REIMBURSEMENT UPDATE

BCBSWY Newsroom

| May 12, 2025

L8699 Update

Effective July 1, 2025, Blue Cross Blue Shield of Wyoming (BCBSWY) will update the process for how providers bill L8699. Currently, L8699 providers bill…

| April 29, 2025

Provider Updates Moving Platforms

BCBSWY is in the process of transitioning our communications from Constant Contact to Salesforce Marketing Cloud. This is a much-needed upgrade to serve our…

| April 4, 2025

Redirection of Care Update – addition of Saphnelo

Effective May 1, 2025, Blue Cross Blue Shield of Wyoming (BCBSWY) will add the following medication to the Redirection of Care program. Saphnelo (HCPCS…

Fewer Hassles. Better Service.

I am a...

I need to...

Who We Are

Helpful Links

We comply with applicable Federal civil rights laws and do not discriminate on the basis of race, color, national origin, age, disability, or sex, including sexual orientation, gender identity, or gender expression. We also provide language assistance. Read our Nondiscrimination and Language Assistance notice.

Prior Authorization Added for LOQTORZI™

Holiday Closure